WO2000042017A1
(en)
*
|
1999-01-15 |
2000-07-20 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Phenanthridine-n-oxides with pde-iv inhibiting activity
|
ATE294793T1
(de)
|
1999-01-15 |
2005-05-15 |
Altana Pharma Ag |
Phenantrhridin-n-oxides mit pde-iv hemmender wirkung
|
MXPA02001830A
(es)
|
1999-08-21 |
2002-08-12 |
Byk Gulden Lomberg Chem Fab |
Combinacion sinergica de inhibidores de pde y agonista de beta 2 adrenoceptor.
|
US6953774B2
(en)
|
2000-08-11 |
2005-10-11 |
Applied Research Systems Ars Holding N.V. |
Methods of inducing ovulation
|
PL365443A1
(en)
|
2001-01-31 |
2005-01-10 |
Pfizer Products Inc. |
Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
|
US7250518B2
(en)
|
2001-01-31 |
2007-07-31 |
Pfizer Inc. |
Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
|
BR0116852A
(pt)
|
2001-01-31 |
2004-02-25 |
Pfizer Prod Inc |
Derivados biarilados de nicotinamida úteis como inibidores de isozimas pde4
|
MXPA03006885A
(es)
|
2001-01-31 |
2003-11-13 |
Pfizer Prod Inc |
Derivados de eteres utiles como agentes inhibidores de las isozimas pde4.
|
MXPA03010672A
(es)
*
|
2001-05-23 |
2004-03-02 |
Tanabe Seiyaku Co |
Composicion para el tratamiento regenerativo de enfermedades del cartilago.
|
DE60233884D1
(de)
*
|
2001-10-16 |
2009-11-12 |
Memory Pharmaceutical Corp |
4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidon-derivate als pde-4-hemmer zur behandlung von neurologischen syndromen
|
MY130622A
(en)
*
|
2001-11-05 |
2007-07-31 |
Novartis Ag |
Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
|
DK1908463T3
(da)
|
2001-12-14 |
2011-11-28 |
Merck Serono Sa |
Fremgangsmåder til at inducere ægløsning ved anvendelse af en ikke polypeptid-CAMP-niveaumodulator
|
BR0315705A
(pt)
|
2002-11-19 |
2005-09-06 |
Memory Pharm Corp |
Inibidores de fosfodiesterase-4
|
GB0229281D0
(en)
*
|
2002-12-16 |
2003-01-22 |
Novartis Ag |
Organic compounds
|
SG169900A1
(en)
*
|
2003-04-16 |
2011-04-29 |
Memory Pharm Corp |
4 - (3,4 - disubstituted phenyl) - pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors
|
CN1809559B
(zh)
*
|
2003-04-18 |
2010-06-02 |
记忆药物公司 |
作为磷酸二酯酶4抑制剂的吡唑衍生物
|
AR044519A1
(es)
|
2003-05-02 |
2005-09-14 |
Novartis Ag |
Derivados de piridin-tiazol amina y de pirimidin-tiazol amina
|
MY141255A
(en)
|
2003-12-11 |
2010-03-31 |
Memory Pharm Corp |
Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
|
GB0401334D0
(en)
|
2004-01-21 |
2004-02-25 |
Novartis Ag |
Organic compounds
|
US20090042951A1
(en)
*
|
2004-02-20 |
2009-02-12 |
Robert Danziger |
Blood Pressure Reduction in Salt-Sensitive Hypertension
|
GB0411056D0
(en)
|
2004-05-18 |
2004-06-23 |
Novartis Ag |
Organic compounds
|
US20050282818A1
(en)
*
|
2004-06-22 |
2005-12-22 |
Rigel Pharmaceuticals, Inc. |
Ubiquitin ligase inhibitors
|
CN101018791A
(zh)
*
|
2004-09-14 |
2007-08-15 |
诺瓦提斯公司 |
通过8-卤代-1,7-萘啶衍生物与有机硼酸衍生物反应来制备6,8-取代的1,7-萘啶衍生物的方法以及该方法的中间体
|
CA2584317A1
(en)
*
|
2004-10-15 |
2006-04-27 |
Memory Pharmaceuticals Corporation |
Pyrazole derivatives as phosphodiesterase 4 inhibitors
|
US7585882B2
(en)
*
|
2004-10-20 |
2009-09-08 |
Memory Pharmaceuticals Corporation |
Phosphodiesterase 4 inhibitors
|
GT200500281A
(es)
|
2004-10-22 |
2006-04-24 |
Novartis Ag |
Compuestos organicos.
|
GB0424284D0
(en)
|
2004-11-02 |
2004-12-01 |
Novartis Ag |
Organic compounds
|
GB0426164D0
(en)
|
2004-11-29 |
2004-12-29 |
Novartis Ag |
Organic compounds
|
JP2006241111A
(ja)
*
|
2005-03-04 |
2006-09-14 |
Univ Nihon |
新規ベンゾフロキサン及びその合成法
|
GB0507577D0
(en)
|
2005-04-14 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
EP2258358A3
(en)
|
2005-08-26 |
2011-09-07 |
Braincells, Inc. |
Neurogenesis with acetylcholinesterase inhibitor
|
WO2007025177A2
(en)
|
2005-08-26 |
2007-03-01 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation
|
EP2377530A3
(en)
|
2005-10-21 |
2012-06-20 |
Braincells, Inc. |
Modulation of neurogenesis by PDE inhibition
|
KR20080049113A
(ko)
|
2005-10-21 |
2008-06-03 |
노파르티스 아게 |
Il-13에 대항한 인간 항체 및 치료적 용도
|
DK1954697T3
(da)
*
|
2005-10-21 |
2010-06-14 |
Glaxo Group Ltd |
Peri-kondenserede tricykliske forbindelser, der er anvendelige som antibakterielle midler
|
US20070112017A1
(en)
|
2005-10-31 |
2007-05-17 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
EP1963324B1
(en)
|
2005-12-22 |
2010-04-21 |
Glaxo Group Limited |
Heterocyclic compounds, their preparation and their use as antibacterials
|
GB0526244D0
(en)
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
GB0601951D0
(en)
*
|
2006-01-31 |
2006-03-15 |
Novartis Ag |
Organic compounds
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
SI2013211T1
(sl)
|
2006-04-21 |
2012-07-31 |
Novartis Ag |
Purinski derivati za uporabo kot agonisti receptorja adenozina A A
|
EP2377531A2
(en)
|
2006-05-09 |
2011-10-19 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
US7678808B2
(en)
|
2006-05-09 |
2010-03-16 |
Braincells, Inc. |
5 HT receptor mediated neurogenesis
|
MX2009002496A
(es)
|
2006-09-08 |
2009-07-10 |
Braincells Inc |
Combinaciones que contienen un derivado de 4-acilaminopiridina.
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
ATE502943T1
(de)
|
2006-09-29 |
2011-04-15 |
Novartis Ag |
Pyrazolopyrimidine als pi3k-lipidkinasehemmer
|
EP2089393A1
(en)
|
2006-10-30 |
2009-08-19 |
Novartis AG |
Heterocyclic compounds as antiinflammatory agents
|
DK2104535T3
(da)
|
2007-01-10 |
2011-04-04 |
Irm Llc |
Forbindelser og sammensætninger som kanalaktiverende proteaseinhibitorer
|
JP5244904B2
(ja)
|
2007-05-07 |
2013-07-24 |
ノバルティス アーゲー |
有機化合物
|
AR069637A1
(es)
|
2007-12-10 |
2010-02-10 |
Novartis Ag |
Derivados de pirazinas
|
JP5584138B2
(ja)
|
2008-01-11 |
2014-09-03 |
ノバルティス アーゲー |
キナーゼ阻害剤としてのピリミジン類
|
US8268834B2
(en)
|
2008-03-19 |
2012-09-18 |
Novartis Ag |
Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
|
JP2011522860A
(ja)
|
2008-06-10 |
2011-08-04 |
ノバルティス アーゲー |
上皮性ナトリウムチャネルブロッカーとしてのピラジン誘導体
|
JP2012516345A
(ja)
|
2009-01-29 |
2012-07-19 |
ノバルティス アーゲー |
星細胞腫治療用置換ベンゾイミダゾール
|
WO2010099217A1
(en)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
US8389526B2
(en)
|
2009-08-07 |
2013-03-05 |
Novartis Ag |
3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
|
AU2010283806A1
(en)
|
2009-08-12 |
2012-03-01 |
Novartis Ag |
Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation
|
ES2709108T3
(es)
|
2009-08-17 |
2019-04-15 |
Intellikine Llc |
Compuestos heterocíclicos y usos de los mismos
|
AU2010284972A1
(en)
|
2009-08-20 |
2012-03-08 |
Novartis Ag |
Heterocyclic oxime compounds
|
EP2813227A1
(en)
|
2009-10-22 |
2014-12-17 |
Vertex Pharmaceuticals Incorporated |
Compositions for treatment of cystic fibrosis and other chronic diseases
|
US8247436B2
(en)
|
2010-03-19 |
2012-08-21 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of CF
|
LT2593452T
(lt)
|
2010-07-14 |
2017-04-10 |
Novartis Ag |
Heterocikliniai junginiai, kaip ip receptoriaus agonistai
|
WO2012034095A1
(en)
|
2010-09-09 |
2012-03-15 |
Irm Llc |
Compounds and compositions as trk inhibitors
|
UY33597A
(es)
|
2010-09-09 |
2012-04-30 |
Irm Llc |
Compuestos y composiciones como inhibidores de la trk
|
US8372845B2
(en)
|
2010-09-17 |
2013-02-12 |
Novartis Ag |
Pyrazine derivatives as enac blockers
|
EP2673277A1
(en)
|
2011-02-10 |
2013-12-18 |
Novartis AG |
[1, 2, 4]triazolo [4, 3 -b]pyridazine compounds as inhibitors of the c-met tyrosine kinase
|
US9127000B2
(en)
|
2011-02-23 |
2015-09-08 |
Intellikine, LLC. |
Heterocyclic compounds and uses thereof
|
WO2012116217A1
(en)
|
2011-02-25 |
2012-08-30 |
Irm Llc |
Compounds and compositions as trk inhibitors
|
UY34305A
(es)
|
2011-09-01 |
2013-04-30 |
Novartis Ag |
Derivados de heterociclos bicíclicos para el tratamiento de la hipertensión arterial pulmonar
|
BR112014006223A8
(pt)
|
2011-09-15 |
2018-01-09 |
Novartis Ag |
3-(quinolin-6-iltio)-[1,2,4-triazol[4,3-a] piradinas 6-substituídas, seus usos, composições farmacêuticas, e combinação
|
US9056867B2
(en)
|
2011-09-16 |
2015-06-16 |
Novartis Ag |
N-substituted heterocyclyl carboxamides
|
WO2013038373A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine amide derivatives
|
CN103946221B
(zh)
|
2011-09-16 |
2016-08-03 |
诺华股份有限公司 |
用于治疗囊性纤维化的杂环化合物
|
WO2013038378A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine amide derivatives
|
WO2013038381A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
Pyridine/pyrazine amide derivatives
|
JP6130391B2
(ja)
|
2011-11-23 |
2017-05-17 |
インテリカイン, エルエルシー |
Mtor阻害剤を使用する強化された治療レジメン
|
EP2804603A1
(en)
|
2012-01-10 |
2014-11-26 |
President and Fellows of Harvard College |
Beta-cell replication promoting compounds and methods of their use
|
JP6073923B2
(ja)
|
2012-01-13 |
2017-02-01 |
ノバルティス アーゲー |
肺動脈高血圧症(pah)および関連障害の治療のためのip受容体アゴニストとしての縮合ピロール
|
US8809340B2
(en)
|
2012-03-19 |
2014-08-19 |
Novartis Ag |
Crystalline form
|
CN104245701A
(zh)
|
2012-04-03 |
2014-12-24 |
诺华有限公司 |
有酪氨酸激酶抑制剂的组合产品和其应用
|
JP5907005B2
(ja)
*
|
2012-09-04 |
2016-04-20 |
エヌ・イーケムキャット株式会社 |
ビフェニル化合物の合成方法
|
JP5907006B2
(ja)
*
|
2012-09-04 |
2016-04-20 |
エヌ・イーケムキャット株式会社 |
ビフェニル化合物の合成方法
|
ES2637719T3
(es)
|
2013-02-13 |
2017-10-16 |
Novartis Ag |
Compuestos heterocíclicos agonistas del receptor IP
|
US9073921B2
(en)
|
2013-03-01 |
2015-07-07 |
Novartis Ag |
Salt forms of bicyclic heterocyclic derivatives
|
EP2968340A4
(en)
|
2013-03-15 |
2016-08-10 |
Intellikine Llc |
COMBINING KINASE INHIBITORS AND USES THEREOF
|
WO2015084804A1
(en)
|
2013-12-03 |
2015-06-11 |
Novartis Ag |
Combination of mdm2 inhibitor and braf inhibitor and their use
|
PT3134396T
(pt)
|
2014-04-24 |
2019-12-16 |
Novartis Ag |
Derivados de amino piridina como inibidores da fosfatidilinositol 3-quinase
|
US10004732B2
(en)
|
2014-04-24 |
2018-06-26 |
Novartis Ag |
Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
|
AU2014391610B2
(en)
|
2014-04-24 |
2018-01-25 |
Novartis Ag |
Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
|
US9741941B2
(en)
|
2014-04-29 |
2017-08-22 |
Universal Display Corporation |
Organic electroluminescent materials and devices
|
WO2016011658A1
(en)
|
2014-07-25 |
2016-01-28 |
Novartis Ag |
Combination therapy
|
MX2017001461A
(es)
|
2014-07-31 |
2017-05-11 |
Novartis Ag |
Terapia de combinacion.
|
BR112021024668A2
(pt)
|
2019-06-10 |
2022-05-31 |
Novartis Ag |
Derivado de piridina e pirazina para o tratamento de fc, dpoc e bronquiectasia
|
PE20220346A1
(es)
|
2019-08-28 |
2022-03-14 |
Novartis Ag |
Derivados de 1,3-fenil heteroarilo sustituidos y su uso en el tratamiento de enfermedades
|
TW202140550A
(zh)
|
2020-01-29 |
2021-11-01 |
瑞士商諾華公司 |
使用抗tslp抗體治療炎性或阻塞性氣道疾病之方法
|